Principal Financial Group
IDIX

Principal Financial Group’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Principal Financial Group’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-18,370
Closed -$443K – 2281
2014
Q2 		$443K Sell
18,370
-12,779
-41% -$133K ﹤0.01% 1885
2014
Q1 		$188K Buy
+31,149
New +$217K ﹤0.01% 2145
2013
Q3 		– Sell
-45,657
Closed -$165K – 2324
2013
Q2 		$165K Buy
+45,657
New +$187K ﹤0.01% 2127

Principal Financial Group's IDIX Position: Q3 2014 in Review

Principal Financial Group sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 18,370 shares — an estimated $443K sold.

Principal Financial Group first reported a position in IDIX in Q2 2013 and held it in 3 quarters. The position peaked at $443K in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • Principal Financial Group reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Principal Financial Group sold 18,370 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $443K.
  • Principal Financial Group first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 3 quarters.
  • Principal Financial Group's IDENIX PHARMACEUTICALS INC position peaked at $443K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Principal Financial Group's 13F filing for Q3 2014, filed 13 Nov 2014.